The inaugural MQPH 2018 Conference will take place at Keble College, Oxford from 23 – 28 September 2018, and will bring together people from a diversity of sectors. There has never been an opportunity for the diverse stakeholders involved in medicine quality and drug regulation to come together before – within the framework of a specific academic conference – to share ideas and expertise, and to outline the coordinated steps that need to be taken to tackle the problem on an international scale. Please submit your abstract by 1 June 2018.
The Oxford Senior Executive Programme in Global Health aims to provide participants with cutting edge research updates delivered by world-renowned researchers in the field of global health. 3 - 9 September 2018 at Exeter College. The programme will be structured with discussions around the opportunities for and challenges in generating relevant evidence, synthesizing existing evidence, using evidence to inform policy, implementing complex interventions and evaluating such interventions
Infections such as dengue and Japanese encephalitis are important problems in Laos but confirmed data are lacking, particularly from outside the capital Vientiane. Rapid diagnostic tests that can be kept at tropical room temperature help better diagnosis and treatment, and also inform policy to implement vaccination programmes.
The Royal Society Summer Science Exhibition is one of the UK's most prestigious science festivals, offering a packed programme of events and more than twenty exhibits of hands on science and technology. This year scientists from the Department of Biochemistry and the Jenner Institute have collaborated on the 'Designer Malaria Vaccines' exhibit, which explores how structural biology is raising hopes for a vaccine against this killer parasite.
ASTMH nominated Professor Rose McGready, SMRU Deputy Director, as an Honorary International Fellow. Rose received the prestigious award in recognition of outstanding accomplishment by an “individual not an American citizen who has made eminent contributions to some phase of tropical medicine and hygiene”.
The leading Oxford’s chimpanzee adenovirus vaccine platform has been engineered as a Zika vaccine, opening the door to clinical trials at the University of Oxford and Mexico. The development was published in Nature Communications in a multinational team effort lead by Prof. Arturo Reyes-Sandoval, the Jenner Institute (NDM) in collaboration with Imperial College London, University of Glasgow, Harvard Medical School, and the Oswaldo Cruz Foundation in Brazil.